Journal of Neurodevelopmental Disorders

Papers
(The TQCC of Journal of Neurodevelopmental Disorders is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Feasibility of delivering parent-implemented NDBI interventions in low-resource regions: a pilot randomized controlled study54
Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases48
Focus on your locus with a massively parallel reporter assay45
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group43
Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC)41
Long-term follow-up of telehealth-enabled behavioral treatment for challenging behaviors in boys with fragile X syndrome37
Consistency of parent-report SLC6A1 data in Simons Searchlight with Provider-Based Publications34
Atypical connectivity in the cortico-striatal network in NF1 children and its relationship with procedural perceptual-motor learning and motor skills33
Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study33
Neural patterns elicited by lexical processing in adolescents with specific language impairment: support for the procedural deficit hypothesis?32
RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer’s disease, and normative aging31
The effect of autistic traits on response to and side-effects of pharmacological ADHD treatment in children with ADHD: results from a prospective clinical cohort27
Innovative computational approaches shed light on genetic mechanisms underlying cognitive impairment among children born extremely preterm25
Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome25
LiCl treatment leads to long-term restoration of spine maturation and synaptogenesis in adult Tbr1 mutants25
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)24
Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes24
0.06494402885437